Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Prostaglandins, Platelets, Lipids -

Prostaglandins, Platelets, Lipids (eBook)

New Developments in Atherosclerosis
eBook Download: PDF
2014 | 1. Auflage
164 Seiten
Elsevier Science (Verlag)
978-1-4831-6513-4 (ISBN)
Systemvoraussetzungen
24,95 inkl. MwSt
(CHF 24,35)
Der eBook-Verkauf erfolgt durch die Lehmanns Media GmbH (Berlin) zum Preis in Euro inkl. MwSt.
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
Prostaglandins, Platelets, Lipids: New Developments in Atherosclerosis focuses on developments pertaining to atherosclerosis and suggested novel approaches for its prevention, treatment, and complications. The selection first underscores the biological importance and therapeutic potential of prostacyclin and rationale for the suppression of platelet aggregation and thrombosis by dietary manipulation of fatty acids. Discussions focus on eicosapentaenoic acid as a potential antithrombotic substance, vascular effects of prostacyclin, antithrombotic and hemostatic effects of prostacyclin, fatty acids, prostacyclin, and thrombosis, and therapeutic uses of prostacyclin. The text then examines prostaglandins and hypertension, role of platelets in stroke and transient ischemic attack, and antiplatelet agents in the prevention of acute coronary events. Topics include thrombosis and clinical complications of atherosclerosis, mechanisms in thrombosis, vascular prostaglandins and antihypertensive mechanisms, and renal prostaglandins and antihypertensive mechanisms. The book ponders on a specific inhibitor of thrombin and cardiovascular actions of prostacyclin in man, including prostacyclin and angina pectoris, prostacyclin therapy for peripheral arterial disease, and hemodynamic changes induced by prostacyclin. The selection is a dependable source of data for researchers interested in atherosclerosis.
Prostaglandins, Platelets, Lipids: New Developments in Atherosclerosis focuses on developments pertaining to atherosclerosis and suggested novel approaches for its prevention, treatment, and complications. The selection first underscores the biological importance and therapeutic potential of prostacyclin and rationale for the suppression of platelet aggregation and thrombosis by dietary manipulation of fatty acids. Discussions focus on eicosapentaenoic acid as a potential antithrombotic substance, vascular effects of prostacyclin, antithrombotic and hemostatic effects of prostacyclin, fatty acids, prostacyclin, and thrombosis, and therapeutic uses of prostacyclin. The text then examines prostaglandins and hypertension, role of platelets in stroke and transient ischemic attack, and antiplatelet agents in the prevention of acute coronary events. Topics include thrombosis and clinical complications of atherosclerosis, mechanisms in thrombosis, vascular prostaglandins and antihypertensive mechanisms, and renal prostaglandins and antihypertensive mechanisms. The book ponders on a specific inhibitor of thrombin and cardiovascular actions of prostacyclin in man, including prostacyclin and angina pectoris, prostacyclin therapy for peripheral arterial disease, and hemodynamic changes induced by prostacyclin. The selection is a dependable source of data for researchers interested in atherosclerosis.

Front Cover 1
Prostaglandins, Platelets, Lipids: New Developments in Atherosclerosis 4
Copyright Page 5
Table of Contents 6
Acknowledgments 8
Introduction 10
Chapter 1. The Biological Importance and Therapeutic Potential of Prostacyclin 14
Objectives 14
Vascular Effects of Prostacyclin 16
Antithrombotic and Hemostatic Effects of Prostacyclin 17
Prostacyclin-Thromboxane A2 Balance and Antithrombotic Therapy 22
Prostacyclin, Fatty Acids and Thrombosis 25
Thromboxane A2-Prostacyclin Balance in Other Pathologicsd States 27
Therapeutic Uses of Prostacyclin 28
References 30
Self-Evaluation Quiz 43
Chapter 2. Rationale for the Suppression of Platelet Aggregation and Thrombosis by Dietary Manipulation of Fatty Acids 46
Objectives 46
3 Series PG Products: Synthetic Pathway and Platelet Effects 48
The Potential of PGD3 as an Antithrombotic Agent 49
Eicosapentaenoic Acid as a Potential Antithrombotic Substance 51
1 Series PG Products and Platelet Aggregation —Mechanism of Action 54
Conclusion 57
References 58
Self-Evaluzation Quiz 60
Chapter 3. Prostaglandins and Hypertension 62
Objectives 62
Vascular Prostaglandins and Antihypertensive Mechanisms 66
Renal Prostaglandins and Antihypertensive Mechanisms 70
Summary 79
Acknowledgments 79
References 79
Self-Evaluation Quiz 85
Chapter 4. Antiplatelet Agents in the Prevention of Acute Coronary Events 88
Objectives 88
References 104
Self-Evaluation Quiz 105
Chapter 5. Role of Platelets in Stroke and Transient Ischemic Attack 108
Objectives 108
Thrombosis and Clinical Complications of Atherosclerosis 108
Thrombosis and the Clinical Complications of Atherosclerosis 114
Mechanisms in Thrombosis 117
Summary 120
References 122
Self-Evaluation Quiz 128
Chapter 6. Cardiovascular Actions of Prostacyclin in Man 132
Objectives 132
Hemodynamic Changes Induced by Prostacyclin (PGI2) 132
Prostacyclin Therapy for Peripheral Arterial Disease 135
Prostacyclin and Angina Pectoris 138
Side Effects of PGI2 Therapy 140
Conclusion 141
References 141
Self-Evaluation Quiz 143
Chapter 7. A Specific Inhibitor of Thrombin: Effects on the Arachidonic Acid Cascade 144
Objective 144
References 149
Self-Evaluation Quiz 150
Discussion 152
Answers to Self-Evaluation Quizzes 162
Subject Index 164

Erscheint lt. Verlag 23.5.2014
Sprache englisch
Themenwelt Sachbuch/Ratgeber Gesundheit / Leben / Psychologie Krankheiten / Heilverfahren
Medizin / Pharmazie Allgemeines / Lexika
Naturwissenschaften Biologie Biochemie
Naturwissenschaften Physik / Astronomie Angewandte Physik
Technik
ISBN-10 1-4831-6513-2 / 1483165132
ISBN-13 978-1-4831-6513-4 / 9781483165134
Haben Sie eine Frage zum Produkt?
PDFPDF (Adobe DRM)
Größe: 20,2 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Diagnostik - Epidemiologie - Therapie

von Sebastian Schulz-Stübner; Markus Dettenkofer …

eBook Download (2023)
Springer Berlin Heidelberg (Verlag)
CHF 45,90
Endlich erkennen - richtig behandeln

von Wolfgang Brückle

eBook Download (2024)
Trias (Verlag)
CHF 15,60